Bernard Naughton

Bernard Naughton

Research Fellow


Saïd Business School
University of Oxford
Park End Street
Oxford
OX1 1HP

Profile

Bernard has a PhD in science and technology in medicine and is a clinical pharmacist by profession.

Prior to Bernard’s academic career he worked as a specialist clinical pharmacist at Oxford University Hospitals NHS Foundation Trust where he still performs research and clinical work on a sessional basis. Bernard is also a member of the Royal Pharmaceutical Society of Great Britain and the Academy of Management.

Research

Bernard’s research concerns leadership, health care and technology.

Bernard’s research examines supply chain traceability, major project leadership, responsible innovation and impact. Bernard’s current research project is funded by the Norwegian Research Council and concerns responsible innovation and the experiences of digital health firms. Bernard’s research is based within public sector organisations with a particular focus on health care.

Ongoing research:

  • Supply Chain Traceability and Falsified Medicines
  • Major Project Leadership and Impact
  • Responsible Research and Innovation in Digital Health
  • Organisational Stigma in Health Care

Publications

Responsible innovation and commercialisation in the university context: a case study of an academic entrepreneur in digital healthcare

Chapter  |  Responsible Innovation in Digital Health Empowering the Patient  | 
  • BERNARD NAUGHTON,
  • Lene Foss
  • Bernard Naughton,
  • Lindsey Roberts,
  • Sue Dopson,
  • David Brindley,
  • Stephen Chapman
Health Care
Organisation Studies

International Counterfeit Medicines Regulation

Chapter  |  Fundamentals of International Regulatory Affairs  | 
  • B Naughton
  • Bernard Naughton,
  • Lindsey Roberts,
  • Sue Dopson,
  • Stephen Chapman,
  • David Brindley
Health Care
Organisation Studies
See more publications

Engagement

Bernard performs consultancy work which aims to translate his research findings into practice.

Bernard aims to generate impact through engagement with external organisations including charities, NHS hospitals, professional and regulatory bodies, private technology firms, and pharmaceutical companies.